instruction:
Given a sentence, an entity and its sentiment towards the entity, verify if it is the correct sentiment towards the entity. Answer should be yes or no. Note that URLs in the text have been replaced with [Link].
question:
Verify if the sentiment of the following document towards the entity Steve Bannon is Neutral . Appearing in SNLâs âMorning Joeâ sketch with Kate McKinnon playing Mika Brzezinski and Alex Moffat as Joe Scarborough  Murray pulled down the hood of a dark cloak to reveal himself as  Bannon . (In the past  the show has portrayed  Bannon  as a cloaked Grim Reaper character.)
answer:
yes


question:
Verify if the sentiment of the following document towards the entity Chris Christie is Positive . The prepared text of  his  remarks didn't show  him  invoking the name of  his  friend  President Donald Trump. But  he  called it an "honor" to chair the White House's opioid commission.
answer:
yes


question:
Verify if the sentiment of the following document towards the entity David Mitchell is Neutral . David Mitchell  66  has multiple myeloma  a blood cancer that is incurable but treatable. To stay alive   he  takes $440 000 worth of drugs a year.  Mitchell  counts  himself  as lucky.  He  has Medicare and can afford to buy Medicare Supplement Plan B  so  his  insurance covers  his  drugs. But not everyone is so fortunate  which is why instead of quietly retiring in  his  60s   he  founded a nonprofit to take on high drug prices. Patients for Affordable Drugs launched earlier this year  and it’s already making noise. On August 29  for example  just one day before the Food and Drug Administration approved a groundbreaking new cancer therapy called Kymriah from the Swiss pharma company Novartis   Mitchell  was in a meeting with several Novartis executives to talk about its price.  Mitchell  did not know then that FDA approval was so imminent  but  he  did know that whenever Kymriah did get to market  it would be astronomically expensive. Kymriah is the first in the new class of therapies known as CAR-T  in which a patients’ own T cells are genetically engineered to go after cancer.  Mitchell  implored Novartis to price Kymriah fairly.
answer:

no